z-logo
open-access-imgOpen Access
Use of teduglutide for short bowel syndrome and Crohn�s disease in a patient treated with ustekinumab and vedolizumab dual biologic therapy
Author(s) -
Lidia Martí Romero,
Laura Peño Muñoz,
Vanesa Martínez Escapa,
Joaquín Hinojosa del Val
Publication year - 2022
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2022.9194/2022
Subject(s) - medicine , ustekinumab , infliximab , crohn's disease , prednisone , rectovaginal fistula , surgery , colonoscopy , adalimumab , vedolizumab , short bowel syndrome , azathioprine , fistula , bowel resection , gastroenterology , disease , colorectal cancer , parenteral nutrition , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here